Back to top

Image: Bigstock

LogicBio Therapeutics (LOGC) Jumps: Stock Rises 6.1%

Read MoreHide Full Article

LogicBio Therapeutics, Inc. (LOGC - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.41 to $7.00 in the past one-month time frame.

The company has seen one positive estimate revision in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for LogicBio Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

LogicBio Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. 

LogicBio Therapeutics, Inc. Price

A better-ranked stock in the Medical - Biomedical and Genetics industry is Emergent Biosolutions Inc (EBS - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.3% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Emergent Biosolutions Inc. (EBS) - free report >>

LogicBio Therapeutics, Inc. (LOGC) - free report >>